Asset Management bought shares of Rigel Pharmaceuticals, Inc., and Citigroup issued a buy rating on the company.
2 reports, 1 independent
Updated Aug 27
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Asset Management bought shares of Rigel Pharmaceuticals, Inc., and Citigroup issued a buy rating on the company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Asset Management
Nothing else this week.
-
Citigroup
American investment bank and financial services corporation
Related events
- Citigroup restated a buy rating on shares of Intensity Therapeutics.
- Citigroup reiterated a buy rating on Halma shares.
- Citigroup maintained a market outperform rating for Ethos Technologies Inc. on November 6, 2026.
- Citigroup raised its price target and gave a buy rating for Glaukos, while Leana Wen sold Glaukos stock.
- Citigroup boosted its price target and gave a buy rating for Wholesale Club, with MarketBeat providing consensus data.